CAI
Capital Advisors Inc Portfolio holdings
AUM
$5.57B
1-Year Return
19.67%
This Quarter Return
+9.55%
1 Year Return
+19.67%
3 Year Return
+68%
5 Year Return
+122.04%
10 Year Return
+254.56%
AUM
$3.73B
AUM Growth
+$369M
(+11%)
Cap. Flow
+$81.4M
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
258
New
28
Increased
131
Reduced
59
Closed
11
Top Buys
| 1 |
Exxon Mobil
XOM
|
$35.6M |
| 2 |
Generac Holdings
GNRC
|
$20.7M |
| 3 |
Chevron
CVX
|
$12.3M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$11.2M |
| 5 |
Accenture
ACN
|
$10.9M |
Top Sells
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
$31.8M |
| 2 |
Bristol-Myers Squibb
BMY
|
$18.4M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$17.7M |
| 4 |
Eaton
ETN
|
$14M |
| 5 |
NVIDIA
NVDA
|
$13.7M |
Sector Composition
| 1 | Consumer Staples | 13.87% |
| 2 | Technology | 13.67% |
| 3 | Financials | 9.32% |
| 4 | Healthcare | 8.62% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vanguard Information Technology ETF
VGT
$99.7B
| $963K | 0.03% |
2,101
+72
| +4% | +$33K |
|
127
Enterprise Products Partners
EPD
$68.9B
| $944K | 0.03% |
42,977
-287
| -0.7% | -$6.3K |
|
|
128
Bristol-Myers Squibb
BMY
$95B
| $942K | 0.03% |
15,114
-295,657
| -95% | -$18.4M |
|
129
Vanguard Total Stock Market ETF
VTI
$529B
| $938K | 0.03% |
3,884
+308
| +9% | +$74.4K |
|
130
Amgen
AMGN
$151B
| $936K | 0.03% |
4,161
-3
| -0.1% | -$675 |
|
131
Yum China
YUMC
$16.4B
| $922K | 0.02% |
18,498
| – | – |
|
132
Valero Energy
VLO
$48.3B
| $913K | 0.02% |
12,153
+159
| +1% | +$11.9K |
|
133
Novanta
NOVT
$4.15B
| $882K | 0.02% |
5,000
| – | – |
|
134
General Dynamics
GD
$86.7B
| $873K | 0.02% |
4,188
-500
| -11% | -$104K |
|
135
iShares MSCI EAFE ETF
EFA
$65.9B
| $869K | 0.02% |
+11,040
| New | +$869K |
|
136
Vanguard Dividend Appreciation ETF
VIG
$95.7B
| $869K | 0.02% |
5,060
-507
| -9% | -$87.1K |
|
137
Costco
COST
$424B
| $837K | 0.02% |
1,474
+26
| +2% | +$14.8K |
|
138
SPDR S&P Dividend ETF
SDY
$20.6B
| $810K | 0.02% |
6,276
| – | – |
|
139
Phillips 66
PSX
$53.2B
| $800K | 0.02% |
11,046
-235
| -2% | -$17K |
|
140
Opko Health
OPK
$1.1B
| $792K | 0.02% |
164,625
| – | – |
|
141
Merck
MRK
$210B
| $781K | 0.02% |
10,197
+3,508
| +52% | +$269K |
|
142
RTX Corp
RTX
$212B
| $748K | 0.02% |
8,688
-200
| -2% | -$17.2K |
|
143
Eli Lilly
LLY
$666B
| $731K | 0.02% |
2,646
-102
| -4% | -$28.2K |
|
144
iShares Morningstar Growth ETF
ILCG
$2.94B
| $727K | 0.02% |
+10,125
| New | +$727K |
|
145
Colgate-Palmolive
CL
$67.6B
| $719K | 0.02% |
8,428
+109
| +1% | +$9.3K |
|
146
Dimensional US Core Equity 2 ETF
DFAC
$37.4B
| $703K | 0.02% |
24,257
| – | – |
|
147
Uber
UBER
$192B
| $701K | 0.02% |
19,685
-9,000
| -31% | -$320K |
|
148
Philip Morris
PM
$251B
| $691K | 0.02% |
7,278
+414
| +6% | +$39.3K |
|
149
AT&T
T
$212B
| $690K | 0.02% |
37,125
-992
| -3% | -$18.4K |
|
150
SPDR S&P MidCap 400 ETF Trust
MDY
$23.9B
| $674K | 0.02% |
+1,301
| New | +$674K |
|